Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|August 5, 2004
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinomaElisabeth Miot-Noirault, Jean Legault, Florent Cachin, et al.
The Medical Journal of Australia|February 22, 2005
Clinical experience with the first combined positron emission tomography/computed tomography scanner in AustraliaW F Eddie Lau, David S Binns, Robert E Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2019
Stimulated Thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid CancersBertrand Barres, Antony Kelly, Fabrice Kwiatkowski, et al.
American Journal of Cancer Research|June 21, 2019
Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundanceMohamad Yakhni, Arnaud Briat, Abderrahim El Guerrab, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 TreatmentAnthime Flaus, Vincent Habouzit, Nicolas de Leiris, et al.
Frontiers in Endocrinology|October 16, 2019
Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid CancerClément Bouvet, Bertrand Barres, Fabrice Kwiatkowski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2011
First ex vivo study demonstrating that 99mTc-NTP 15-5 radiotracer binds to human articular cartilageFlorent Cachin, Stéphane Boisgard, Aurélien Vidal, et al.
Pageof 6